Literature DB >> 21372009

Different impact of ALS on laminin isoforms in human extraocular muscles versus limb muscles.

Jing-Xia Liu1, Thomas Brännström, Peter M Andersen, Fatima Pedrosa-Domellöf.   

Abstract

PURPOSE: To determine the impact of amyotrophic lateral sclerosis (ALS) on the extraocular muscles (EOMs) by examining the laminin isoform composition of the basement membranes (BMs) in EOMs and limb muscles from donors with ALS.
METHODS: Muscle samples collected at autopsy from ALS donors and from transgenic mice overexpressing human superoxide dismutase type I mutations (D90A or G93A), and age-matched controls were analyzed with immunohistochemistry using antibodies against laminin chain (Ln)α2, Lnα4, Lnα5, Lnβ1, Lnβ2, and Lnγ1. Neuromuscular junctions (NMJs) were identified with α-bungarotoxin.
RESULTS: Lnα2, the hallmark chain of skeletal muscle, and Lnβ2 were absent or partially absent from the BMs in a variable number of muscle fibers in most of the ALS EOMs. Three ALS donors showed dramatic decrease in the levels of these chains around their muscle fibers and NMJs. Changes in Lnα2 were not age related and were also present in EOMs of ALS mouse models. Lnα4 was preserved in the majority of NMJs in EOMs but absent in the majority of NMJs in limb muscle of ALS. The BMs around muscle fibers, NMJs, nerves, and blood vessels of the majority of EOMs of ALS donors had rather normal appearance and laminin composition, but heterogeneity was observed among EOM samples of individual ALS donors and between ALS donors.
CONCLUSIONS: The present study showed distinct impact of ALS on EOMs compared with limb muscles. The EOMs maintained a normal laminin composition in their NMJs, which may be instrumental for the fact that they are not typically affected in ALS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21372009     DOI: 10.1167/iovs.10-7132

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  Wnt and extraocular muscle sparing in amyotrophic lateral sclerosis.

Authors:  Linda K McLoon; Vahid M Harandi; Thomas Brännström; Peter M Andersen; Jing-Xia Liu
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-14       Impact factor: 4.799

Review 2.  Neuromuscular Junction Dysfunction in Amyotrophic Lateral Sclerosis.

Authors:  Sagar Verma; Shiffali Khurana; Abhishek Vats; Bandana Sahu; Nirmal Kumar Ganguly; Pradip Chakraborti; Mandaville Gourie-Devi; Vibha Taneja
Journal:  Mol Neurobiol       Date:  2022-01-08       Impact factor: 5.590

3.  Analysis of neurotrophic factors in limb and extraocular muscles of mouse model of amyotrophic lateral sclerosis.

Authors:  Vahid M Harandi; Susanne Lindquist; Shrikant Shantilal Kolan; Thomas Brännström; Jing-Xia Liu
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

Review 4.  Adducin at the Neuromuscular Junction in Amyotrophic Lateral Sclerosis: Hanging on for Dear Life.

Authors:  Charles Krieger; Simon Ji Hau Wang; Soo Hyun Yoo; Nicholas Harden
Journal:  Front Cell Neurosci       Date:  2016-01-29       Impact factor: 5.505

Review 5.  Neuroprotective Effect of Vascular Endothelial Growth Factor on Motoneurons of the Oculomotor System.

Authors:  Silvia Silva-Hucha; Angel M Pastor; Sara Morcuende
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

6.  Distinct changes in synaptic protein composition at neuromuscular junctions of extraocular muscles versus limb muscles of ALS donors.

Authors:  Jing-Xia Liu; Thomas Brännström; Peter M Andersen; Fatima Pedrosa-Domellöf
Journal:  PLoS One       Date:  2013-02-26       Impact factor: 3.240

7.  Composition, Architecture, and Functional Implications of the Connective Tissue Network of the Extraocular Muscles.

Authors:  Linda K McLoon; André Vicente; Krysta R Fitzpatrick; Mona Lindström; Fatima Pedrosa Domellöf
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-01-01       Impact factor: 4.799

Review 8.  Basal lamina changes in neurodegenerative disorders.

Authors:  Benjamin Nguyen; Gregory Bix; Yao Yao
Journal:  Mol Neurodegener       Date:  2021-12-07       Impact factor: 14.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.